ClinicalTrials.Veeva

Menu

Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Vesicoureteral Reflux

Treatments

Procedure: Endoscopic subureteric injection

Study type

Interventional

Funder types

Other

Identifiers

NCT00815334
2008-10-094

Details and patient eligibility

About

Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatment option for VUR in adults. However, the experience with ESI in adults who have VUR associated with decreased bladder compliance is limited. We evaluated the efficacy of endoscopic subureteral injection treatment for vesicoureteral reflux in adults with decreased bladder compliance.

Enrollment

47 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Who is aged 18 and greater
  • Who underwent endoscopic subureteral injection for vesicoureteral reflux

Exclusion criteria

  • Medical records of whom is not evaluabe

Trial design

47 participants in 2 patient groups

Patients with decreased bladder compliance
Experimental group
Description:
Patients who have decreased bladder compliance
Treatment:
Procedure: Endoscopic subureteric injection
Patients with normal bladder compliance
Active Comparator group
Description:
Patients who have normal bladder compliance
Treatment:
Procedure: Endoscopic subureteric injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems